CLINICAL_TRIALS
trial_result
· 2013-02-15
Clinical Trial Update: Study to Evaluate the Efficacy of Riluzole in Children and Young Adults With Spinal Muscular Atrophy (SMA) [Phase 2, Phase 3]
Summary
A phase 2/3 clinical trial evaluating riluzole for spinal muscular atrophy has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: SMA | Phase 2, Phase 3 | Status: COMPLETED